Zambia has successfully investigated and cleared two suspected cases of Ebola, providing a momentary sigh of relief as the nation intensifies its health surveillance and screening efforts. This proactive stance comes in response to a concerning outbreak of the viral disease in the neighboring Democratic Republic of Congo (DRC).
According to Congolese authorities, the number of suspected cases has climbed to 1,028. Of particular concern to health experts is the specific variant involved: the Bundibugyo strain. Unlike other forms of the virus, there is currently no vaccine available for the Bundibugyo strain, increasing the urgency of containment and monitoring.
Zambia's health ministry acknowledged the high risk of the virus crossing the border but confirmed that laboratory tests for the two suspected cases returned negative results. To mitigate future risks, the ministry has implemented specialized screening tools and protocols. These measures are currently active at all entry points into Zambia and are being applied to individuals exhibiting Ebola-like symptoms within the country.
The Bundibugyo strain, which takes its name from a Ugandan province where it was first identified nearly two decades ago, has alarmed the international medical community. Its danger lies in its ability to spread through densely populated areas while remaining undetected for extended periods, making the process of tracing and isolating contacts significantly more challenging.
The World Health Organization (WHO) notes that Ebola viruses typically begin with sudden flu-like symptoms, including fever, fatigue, malaise, muscle pain, headache, and sore throat. As the disease progresses, patients may experience vomiting and diarrhea, which can eventually lead to internal and external bleeding and multi-organ failure.
Reference(s):
cgtn.com
